NPPB and hydrops fetalis: Echocardiographic parameters, when combined with serological biomarkers like N‐terminal pro‐brain natriuretic peptide (NT‐proBNP), are recommended in current European HF guidelines as highly sensitive but moderately specific markers of HF [17].